Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity.
Front Immunol
; 12: 719077, 2021.
Article
in En
| MEDLINE
| ID: mdl-34394127
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sindbis Virus
/
Antigens, Differentiation
/
Spike Glycoprotein, Coronavirus
/
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19
Aspects:
Patient_preference
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Front Immunol
Year:
2021
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Suiza